AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Starling Oncology, Inc.

$6.53 +$0.73 (+12.59%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$6.65
Day Range
$6.35$6.69
Year Range
$2.32$7.13
Market Cap
652.89M
AVG Volume
1.5M
Trailing/Forward PE
-21.77/-
PEG ratio
0.3
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (USD) · Q
050M100M150M200M25 Q325 Q426 Q126 Q2
STLN Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2161.28M
26 Q1147.44M
25 Q4141.96M
25 Q3136.56M
Net Income (USD) · Q
-20M-15M-10M-5M025 Q325 Q426 Q126 Q2
STLN Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-9.79M
26 Q1-2.49M
25 Q4-7.51M
25 Q3-16.5M
Operating Income (USD) · Q
-10M-7.5M-5M-2.5M025 Q325 Q426 Q126 Q2
STLN Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-4.62M
26 Q1-6.51M
25 Q4-6.91M
25 Q3-8.05M
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: STLN

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

Starling Oncology, Inc.
STLN
Stockpicker

Video analysis: STLN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: STLN

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.